Could Stem Cell Therapy be the Cure in Liver Cirrhosis?

Journal of Clinical and Experimental Hepatology

Volumn 5, Issue 2, 2015, Pages 142-146

  Irfan, Ahmer ^a   Ahmed, Irfan ^b  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b UNIVERSITY OF ABERDEEN   (United Kingdom)

Author keywords

Haematopoetic stem cells; Hepatic progenitor cells; Liver cirrhosis; Mesenchymal stem cells; Stem cell therapy

Indexed keywords

GRANULOCYTE COLONY STIMULATING FACTOR;

CELL ASSAY; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; FEASIBILITY STUDY; HEMATOPOIETIC STEM CELL; HUMAN; LIVER CIRRHOSIS; MESENCHYMAL STEM CELL; OUTCOME ASSESSMENT; PATIENT SAFETY; PRIORITY JOURNAL; REVIEW; STEM CELL MOBILIZATION; STEM CELL TRANSPLANTATION; TREATMENT RESPONSE; TREND STUDY;

EID: 84952877318     PISSN: 09736883     EISSN: 22133453     Source Type: Journal    
DOI: 10.1016/j.jceh.2014.03.042     Document Type: Review

References (35)

1. Hoyert D.L., Xu J. Deaths: preliminary data for 2011. Natl Vital Stat Rep 2013; October 10, 61(6).
2. American Cancer Society Cancer Facts and Figures 2013 2013, American Cancer Society, Atlanta.
3. Zhang Z., Lin H., Shi M., et al. Human umbilical cord mesenchymal stem cells improve liver function and ascites in decompensated liver cirrhosis patients. J Gastroenterol Hepatol 2012; Mar, 27(suppl 2):112-120.
4. Bataller R., Brenner D.A. Liver fibrosis. J Clin Invest 2005; Feb, 115(2):209-218.
5. Kisseleva T., Gigante E., Brenner D.A. Recent advances in liver stem cell therapy. Curr Opin Gastroenterol 2010; Jul, 26(4):395-402.
6. Khan A.A., Parveen N., Mahaboob V.S., et al. Safety and efficacy of autologous bone marrow stem cell transplantation through hepatic artery for the treatment of chronic liver failure: a preliminary study. Transpl Proc 2008; May, 40(4):1140-1144.
7. Kim W.R., Kremers W.K. Benefits of "the benefit model" in liver transplantation. Hepatology 2008; July, 48:697-698.
8. Houlihan D.D., Newsome P.N. Critical review of clinical trials of bone marrow stem cells in liver disease. Gastroenterology 2008; Aug, 135(2):438-450.
9. Almeida-Porada G., Zanjani E.D., Porada C.D. Bone marrow stem cells and liver regeneration. Exp Hematol 2010; Jul, 38(7):574-580.
10. Weissman I.L. Stem cells: units of development, units of regeneration, and units in evolution. Cell 2000; Jan 7, 100(1):157-168.
11. Lakshmipathy U., Verfaillie C. Stem cell plasticity. Blood Rev 2005; Jan, 19(1):29-38.
12. Blau H.M., Brazelton T.R., Weimann J.M. The evolving concept of a stem cell: entity or function?. Cell 2001, 105(7):829-841.
13. Bryder D., Rossi D.J., Weissman I.L. Hematopoietic stem cells: the paradigmatic tissue-specific stem cell. Am J Pathol 2006; Aug, 169(2):338-346.
14. Lagasse E., Connors H., Al-Dhalimy M., et al. Purified hematopoietic stem cells can differentiate into hepatocytes in vivo. Nat Med 2000; Nov, 6(11):1229-1234.
15. Jang Y.Y., Collector M.I., Baylin S.B., Diehl A.M., Sharkis S.J. Hematopoietic stem cells convert into liver cells within days without fusion. Nat Cell Biol 2004; Jun, 6(6):532-539.
16. Mallet V.O., Mitchell C., Mezey E., et al. Bone marrow transplantation in mice leads to a minor population of hepatocytes that can be selectively amplified in vivo. Hepatology 2002; Apr, 35(4):799-804.
17. Ding D.C., Shyu W.C., Lin S.Z. Mesenchymal stem cells. Cell Transpl 2011, 20(1):5-14.
18. Russo F.P., Parola M. Stem cells in liver failure. Best Pract Res Clin Gastroenterol 2012; Feb, 26(1):35-45.
19. Stock P., Staege M.S., Müller L.P., et al. Hepatocytes derived from adult stem cells. Transpl Proc 2008; March, 40(2):620-623.
20. Oh S., Hatch H.M., Petersen B.E. Hepatic oval 'stem' cell in liver regeneration. Seminars Cell Dev Biology 2002; December, 13(6):405-409.
21. Lowes K.N., Brennan B.A., Yeoh G.C., Olynyk J.K. Oval cell numbers in human chronic liver diseases are directly related to disease severity. Am J Pathol 1999; Feb, 154(2):537-541.
22. Kakinuma S., Tanaka Y., Chinzei R., et al. Human umbilical cord blood as a source of transplantable hepatic progenitor cells. Stem Cells 2003, 21(2):217-227.
23. Gaia S., Smedile A., Omede P., et al. Feasibility and safety of G-CSF administration to induce bone marrow-derived cells mobilization in patients with end stage liver disease. J Hepatol 2006; Jul, 45(1):13-19.
24. Terai S., Ishikawa T., Omori K., et al. Improved liver function in patients with liver cirrhosis after autologous bone marrow cell infusion therapy. Stem Cells 2006; Oct, 24(10):2292-2298.
25. Mohamadnejad M., Alimoghaddam K., Mohyeddin-Bonab M., et al. Phase 1 trial of autologous bone marrow mesenchymal stem cell transplantation in patients with decompensated liver cirrhosis. Arch Iran Med 2007; Oct, 10(4):459-466.
26. Mohamadnejad M., Namiri M., Bagheri M., et al. Phase 1 human trial of autologous bone marrow-hematopoietic stem cell transplantation in patients with decompensated cirrhosis. World J Gastroenterol 2007; Jun 28, 13(24):3359-3363.
27. Pai M., Zacharoulis D., Milicevic M.N., et al. Autologous infusion of expanded mobilized adult bone marrow-derived CD34+ cells into patients with alcoholic liver cirrhosis. Am J Gastroenterol 2008; Aug, 103(8):1952-1958.
28. Kharaziha P., Hellstrom P.M., Noorinayer B., et al. Improvement of liver function in liver cirrhosis patients after autologous mesenchymal stem cell injection: a phase I-II clinical trial. Eur J Gastroenterol Hepatol 2009; Oct, 21(10):1199-1205.
29. Khan A.A., Shaik M.V., Parveen N., et al. Human fetal liver-derived stem cell transplantation as supportive modality in the management of end-stage decompensated liver cirrhosis. Cell Transpl 2010, 19(4):409-418.
30. Salama H., Zekri A.R., Bahnassy A.A., et al. Autologous CD34+ and CD133+ stem cells transplantation in patients with end stage liver disease. World J Gastroenterol 2010; Nov 14, 16(42):5297-5305.
31. Nikeghbalian S., Pournasr B., Aghdami N., et al. Autologous transplantation of bone marrow-derived mononuclear and CD133(+) cells in patients with decompensated cirrhosis. Arch Iran Med 2011; Jan, 14(1):12-17.
32. Lin H., Zhang Z., Shi M., et al. Prospective controlled trial of safety of human umbilical cord derived-mesenchymal stem cell transplantation in patients with decompensated liver cirrhosis. Zhonghua Gan Zang Bing Za Zhi 2012; Jul, 20(7):487-491.
33. Terai S., Sakaida I., Yamamoto N., et al. An in vivo model for monitoring trans-differentiation of bone marrow cells into functional hepatocytes. J Biochem 2003; Oct, 134(4):551-558.
34. Vassilopoulos G., Russell D.W. Cell fusion: an alternative to stem cell plasticity and its therapeutic implications. Curr Opin Genet Dev 2003; Oct, 13(5):480-485.
35. Wang X., Willenbring H., Akkari Y., et al. Cell fusion is the principal source of bone-marrow-derived hepatocytes. Nature 2003; Apr 24, 422(6934):897-901.